Astrocytes and microglia: Responses to neuropathological conditions

International Journal of Neuroscience

Volumn 121, Issue 11, 2011, Pages 589-597

  Singh, Sarika ^a   Swarnkar, Supriya ^a   Goswami, Poonam ^a   Nath, Chandishwar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Astrocytes; Microglial cells; Neuropathology

Indexed keywords

CATALASE; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GAMMA INTERFERON; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERLEUKIN 1; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ASTROCYTE; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; MICROGLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; SYSTEMATIC REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; ENCEPHALITIS; HUMANS; MICROGLIA; NEURODEGENERATIVE DISEASES;

EID: 80755125569     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.598981     Document Type: Review

References (137)

1. Acarin, L., Paris, J., Gonzalez, B., et al. (2002). Glial expression of small heat shock proteins following an excitotoxic lesion in the immature rat brain. Glia, 38, 1-14.
2. Albrecht, P. J., Dahl, J. P., Stoltzfus, O. K., et al. (2002). Ciliary neurotrophic factor activates spinal cord astrocytes stimulating their production and release of fbroblast growth factor-2 to increase motor neuron survival. Experimental Neurology, 173, 46-62. (Pubitemid 34081725)
3. Allen, N. J., & Barres, B. A. (2005). Signaling between glia and neurons: Focus on synaptic plasticity. Current Opinion in Neurobiol-ogy, 15, 542-548. (Pubitemid 41394398)
4. Anilkumar, N., Weber, R., Zhang, M., et al. (2008). Nox4 and Nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1347-1354.
5. Ashe, P. C., & Berry, M. D. (2003). Apoptotic signaling cascades. Progress in Neuropsychopharmacology and Biological Psychiatry, 27, 199-214. (Pubitemid 36351488)
6. Belin, M. F., Didier-Bazes, M., Akaoka, H., et al. (1997). Changes in astrocytic glutamate catabolism enzymes following neuronal degeneration or viral infection. Glia, 21, 154-161. (Pubitemid 27389651)
7. Bernhardi, R. V. (2007). Glial cell dysregulation: A new perspective on Alzheimer disease. Neurotoxicity Research, 12, 215-232.
8. Bespalov, M. M., & Saarma, M. (2007). GDNF family receptor complexes are emerging drug targets. Trends in Pharmacological Sciences, 28, 68-74. (Pubitemid 46161837)
9. Bhat, N. R., Zhang, P., & Bhat, A. N. (1999). Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: Role of p38 mitogen-activated protein kinase activation. Journal of Neurochemistry, 72, 472-478. (Pubitemid 29055208)
10. Bi, J., Wang, X. B., Chen, L., et al. (2008). Catalpol protects mesen-cephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity. To x i-cology In Vitro, 22, 1883-1889.
11. Blanc, E. M., Keller, J. N., Fernandez, S., et al. (1998). 4-hydroxynonenal a lipid peroxidation product impairs glutamate transport in cortical astrocytes. Glia, 22, 149-160. (Pubitemid 28084387)
12. Block, M. L., & Hong, J. S. (2007). Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochemical Society Transactions, 35, 1127-1132. (Pubitemid 350206444)
13. Bohn, M. C. (2004). Motoneurons crave glial cell line-derived neu-rotrophic factor. Experimental Neurology, 190, 263-275. (Pubitemid 39504986)
14. Boillee, S., & Cleveland, D. W. (2008). Revisiting oxidative damage in ALS: Microglia, Nox, and mutant SOD1. The Journal of Clinical Investigation, 118, 474-478. (Pubitemid 351206538)
15. Boscá, L., & Hortelano, S. (1999). Mechanisms of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators. Cellular Signalling, 11, 239-244. (Pubitemid 29185125)
16. Brown, G. C., & Borutaite, V. (2004). Inhibition of mitochon-drial complex-I by nitric oxide peroxynitrite and s-nitrosothiols. Biochimica et Biophysica Acta, 1658, 44-49. (Pubitemid 39013232)
17. Bruno, V., Battaglia, G., & Copani, A. (2001). Metabotropic glu-tamate receptor subtypes as targets for neuroprotective drugs. Journal of Cerebral Blood Flow and Metabolism, 21, 1013-1033. (Pubitemid 32823739)
18. Carreras, M. C., Franco, M. C., Peralta, J. G., et al. (2004). Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Molecular Aspects of Medicine, 25, 125-139. (Pubitemid 38401937)
19. Chao, C. C., & Lee, E. H. (1999). Neuroprotective mechanism of glial cell line derived neurotrophic factors on dopamine neurons: Role of antioxidation. Neuropharmacology, 38, 913-916. (Pubitemid 29187351)
20. Chen, Y., Vartiainen, N. E., Ying, W., et al. (2001). Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. Journal of Neurochemistry, 77, 1601-1610. (Pubitemid 32574495)
21. Chenevier-Gobeaux, C., Simonneau, C., Therond, P., et al. (2007). Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activity. Life Science, 81, 1050-1058. (Pubitemid 47432777)
22. Chiang, C. S., Powell, H. C., Gold, L. H., et al. (1996). Macrophage/microglial mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. The Journal of Clinical Investigation, 97, 1512-1524. (Pubitemid 26097042)
23. Chiarini, A., Dal Pra, I., Menapace, L., et al. (2005). Soluble amyloid beta-peptide and myelin basic protein strongly stimulate, alone and in synergism with combined proinfammatory cytokines, the expression of functional nitric oxide synthase-2 in normal adult human astrocytes. International Journal of Molecular Medicine, 16, 801-807.
24. Chuenkova, M. V., & Pereira, M. A. (2000). A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells. Molecular Biology of the Cell, 11, 1487-1498. (Pubitemid 30211044)
25. Chung, Y. C., Kim, S. R., & Jin, B. K. (2010). Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain infam-mation and oxidative stress in an experimental model of Parkinson's disease. The Journal of Immunology, 1852, 1230-1237.
26. Condino-Neto, A., & Newburger, P. E. (1998). NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Archives of Biochemistry and Biophysics, 360, 158-164. (Pubitemid 29001743)
27. De Bernardo, S., Canals, S., Casarejos, M. J., et al. (2004). Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures. Journal of Neurochemistry, 91, 667-682. (Pubitemid 39431161)
28. De Keulenaer, G. W., Alexander, R. W., Ushio-Fukai, M., et al. (1998). Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochemical Journal, 329, 653-657.
29. Desagher, S., Glowinski, J., & Premont, J. (1996). Astrocytes protect neurons from hydrogen peroxide toxicity. The Journal of Neuro-science, 16, 2553-2562. (Pubitemid 26122677)
30. Dimmeler, S., & Zeiher, A. M. (1997). Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide. Nitric Oxide, 1, 275-281. (Pubitemid 28078114)
31. Doetsch F. (2003) The glial identity of neural stem cells. Nature Neu-roscience, 6, 1127-1134. (Pubitemid 37346029)
32. D'onofrio, M., Cuomo, L., Battaglia, G., et al. (2001). Neuro-protection mediated by glial group-II metabotropic glutamate receptors requires the activation of the map kinase and the phosphatidylinositol-3-kinase pathways. Journal of Neurochem-istry, 78, 435-445. (Pubitemid 32729972)
33. Dringen, R., Gutterer, J. M., & Hirrlinger, J. (2000). Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. European Journal of Biochemistry, 267, 4912-4916. (Pubitemid 30641287)
34. Dringen, R., Pfeiffer, B., & Hamprecht, B. (1999). Synthesis of the an-tioxidant glutathione in neurons: Supply by astrocytes of cys-gly as precursor for neuronal glutathione. The Journal of Neuroscience, 19, 562-569. (Pubitemid 29036007)
35. Drukarch, B., Schepens, E., Jongenelen, C. A., et al. (1997). Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione defciency. Brain Research, 770, 123-130. (Pubitemid 27468059)
36. Drukarch, B., Schepens, E., Stoof, J. C., et al. (1998). Astrocyte enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radical Biology and Medicine, 25, 217-220. (Pubitemid 28293157)
37. Dutta, G., Zhang, P., & Liu, B. (2008). The lipopolysaccharide Parkinson's disease animal model: Mechanistic studies and drug discovery. Fundamental and Clinical Pharmacology, 22, 453-464.
38. Eddleston, M., & Mucke, L. (1993). Molecular profle of reactive astrocytes-implications for their role in neurologic disease. Neu-roscience, 54, 15-36. (Pubitemid 23147085)
39. Esiri, M. M. (2007). The interplay between infammation and neu-rodegeneration in CNS disease. The Journal of Neuroimmunology, 184, 4-16. (Pubitemid 46365987)
40. Feuerstein, G. Z., Liu, T., & Barone, F. C. (1994). Cytokines infam-mation and brain injury: Role of tumor necrosis factor-alpha. Cerebrovascular and Brain Metabolism Reviews, 6, 341-360.
41. Frey, R. S., Rahman, A., Kefer, J. C, et al. (2002). PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothe-lial cells. Circulation Research, 90, 1012-1019. (Pubitemid 34633868)
42. Garbayo, E., Aymerich, M. S., Ansorena, E, et al. (2006). Neuro-protective and neurorestorative therapies for the treatment of Parkinson's disease. Anales del Sistema Sanitario de Navarra, 29, 325-335. (Pubitemid 46120756)
43. Gauss, K. A., Nelson-Overton, L. K., Siemsen, D. W., et al. (2007). Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. Journal of Leukocyte Biology, 82, 729-741. (Pubitemid 47367165)
44. Giulian, D., Li, J., Li, X., et al. (1994). The impact of microglia-derived cytokines upon gliosis in the CNS. Developmental Neu-roscience, 16, 128-136.
45. Glozman, S., & Yavin, E. (1997). Lipid peroxides are generated by the fetal rat brain after episodes of global ischemia in utero. Neuro-chemical Research, 22, 201-208. (Pubitemid 27069097)
46. Gomes, F. C., Sousa Vde, O., & Romao, L. (2005). Emerging roles for TGF-beta1 in nervous system development. International Journal of Developmental Neuroscience, 23, 413-424. (Pubitemid 40981867)
47. Gong, L., Wyatt, R. J., Baker, I., et al. (1999). Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminer-gic cell line from dopamine-induced cell death. Neuroscience Letters, 263, 153-156. (Pubitemid 29158951)
48. Goodwin, J. L., Uemura, E., & Cunnick, J. E. (1995). Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Research, 692, 207-214.
49. Goss, J. R., O'Malley, M. E., Zou, L., et al. (1998) Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat. Experimental Neurology, 149, 301-309. (Pubitemid 28115068)
50. Grant, M. M., Barber, V. S., & Griffths H. R. (2005). The presence of ascorbate induces expression of brain derived neurotrophic factor in SH-SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival. Proteomics, 5, 534-540. (Pubitemid 40262070)
51. Gunasingh, M. J., Philip, J. E., Ashok, B. S., et al. (2008). Melatonin prevents amyloid protofbrillar induced oxidative imbalance and biogenic amine catabolism. Life Science, 83, 96-102.
52. Hashioka, S., Klegeris, A., & Monji, A. (2007). Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Experimental Neurology, 206, 33-42. (Pubitemid 46935120)
53. Haydon, P. G. (2001). Glia: Listening and talking to the synapse. Nature Reviews Neuroscience, 2, 185-193. (Pubitemid 33673371)
54. Heaton, M. B., Paiva, M., Madorsky, I., et al. (2003). Effects of ethanol on neurotrophic factors, apoptosis-related proteins, endogenous antioxidants, and reactive oxygen species in neonatal striatum: Relationship to periods of vulnerability. Brain Research Development Brain Research, 140, 237-252. (Pubitemid 36173981)
55. Herrera-Molina, R., & Bernhardi, V. R. (2005). Transforming growth factor-beta 1 produced by hippocampal cells modulates mi-croglial reactivity in culture. Neurobiology of Disease, 19, 229-236. (Pubitemid 40544740)
56. 2+currents in fetal mouse cortical neurons. Journal of Neurochemistry, 82, 495-503. (Pubitemid 34835673)
57. Ji, J. Z., Elyaman, W., Yip, H. K., et al. (2004). CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: The possible involvement of stat3 pathway. The European Journal of Neuroscience, 19, 265-272. (Pubitemid 38177865)
58. Jin, Z., & El-Deiry, W. S. (2005). Overview of cell death signaling pathways. Cancer Biology and Therapy, 4, 139-163. (Pubitemid 41351311)
59. Joosten, E. A., & Houweling, D. A. (2004). Local acute application of BDNF in the lesioned spinal cord anti-infammatory and anti-oxidant effects. Neuroreport, 15, 1163-1166. (Pubitemid 38670073)
60. Kamizato, M., Nishida, K., Masuda, K., et al. (2009). Interleukin 10 inhibits interferon gamma-and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. Journal of Gastroenterology, 44, 1172-1184.
61. Kang, J., Park, E. J., Jou, I., et al. (2001). Reactive oxygen species mediate A beta (25-35) induced activation of BV-2 microglia. Neuroreport, 12, 1449-1452. (Pubitemid 32476145)
62. Kirschner, P. B., Jenkins, B. G., Schulz, J. B., et al. (1996). NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxic-ity and oxidative stress in neonatal animals. Brain Research, 713, 178-185. (Pubitemid 26116260)
63. Kraft, A. D., McPherson, C. A., & Harry, G. J. (2009). Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. Neurotoxicology, 30, 785-793.
64. Kuhle, J., Lindberg, R. L., Regeniter A., et al. (2009). Increased levels of infammatory chemokines in amyotrophic lateral sclerosis. European Journal of Neurology, 16, 771-774.
65. Labie, C., Lafon, C., & Marmouget, C. (1999). Effect of the neuro-protective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex. British Journal of Pharmacology, 127, 139-144. (Pubitemid 29213242)
66. Le, R., & Esquenazi, S. (2002). Astrocytes mediate cerebral cortical neuronal axon and dendrite growth in part by release of fbroblast growth factor. Neurology Research, 24, 81-92. (Pubitemid 34038400)
67. Lee, M., Schwab, C., Yu, S., et al. (2009). Astrocytes produce the an-tiinfammatory and neuroprotective agent hydrogen sulfde. Neu-robiology of Aging, 30, 1523-1534.
68. Lee, Y. J., Han, S. B., Nam, S. Y., et al. (2010). Infammation and Alzheimer's disease. Archives of Pharmacal Research, 33, 1539-1556.
69. Li, L., He, Q., Huang, X., et al. (2010). NOX3-derived reactive oxygen species promote TNF-alpha-induced reductions in hepatocyte glycogen levels via a JNK pathway. FEBS Letters, 584, 995-1000.
70. Li, W., Brakefeld, D., Pan, Y., et al. (2007). Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Experimental Neurology, 203, 457-471. (Pubitemid 46149591)
71. Lin, B., Ginsberg, M. D., Busto, R., et al. (1998). Sequential analysis of subacute and chronic neuronal astrocytic and microglial alterations after transient global ischemia in rats. Acta Neuropatholog-ica, 95, 511-523.
72. Liu, B., Du, L., & Hong, J. S. (2000). Naloxone protects rat dopamin-ergic neurons against infammatory damage through inhibition of microglia activation and superoxide generation. Journal of Pharmacology and Experimental Therapeutics, 293, 607-617. (Pubitemid 30244114)
73. Liu, B., Gao, H. M., Wang, J. Y., Jeohn, G. H., Cooper, C. L., & Hong, J. S. (2002). Role of nitric oxide in infammation-mediated neu-rodegeneration. New York Academy of Sciences, 962, 318-331. (Pubitemid 34592321)
74. Liu, M. H., Lin, Y. S., Sheu, S. Y, et al. (2009). Anti-infammatory effects of daidzein on primary astroglial cell culture. Nutritional Neuroscience, 12, 123-134.
75. Maragakis, N. J., & Rothstein, J. D. (2006). Mechanisms of disease: Astrocytes in neurodegenerative disease. Nature Clinical Practice Neurology, 2, 679-689. (Pubitemid 44782682)
76. Markham, A., Cameron, I., Franklin, P., et al. (2004). BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II. The European Journal of Neuroscience, 20, 1189-1196. (Pubitemid 39233572)
77. +-induced neurotoxi-city along with brain-derived neurotrophic factor induction. Journal of Neurochemistry, 76, 351-360. (Pubitemid 32097014)
78. Mattson, M. P., Lovell, M. A., Furukawa, K., et al. (1995). Neu-rotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2 +concentration, and neurotoxicity and increase antioxidant enzyme activities in hip-pocampal neurons. Journal of Neurochemistry, 65, 1740-1751.
79. McCoy, M. K., & Tansey, M. G. (2008). TNF signaling inhibition in the CNS: Implications for normal brain function and neurode-generative disease. Journal of Neuroinflammation, 17(5), 45.
80. McGeer, P. L., & McGeer, E. G. (2008). Glial reactions in Parkinson's disease. Movement Disorders, 23, 474-483.
81. McNaught, K. S., & Jenner, P. (2000). Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release. Neuroscience Letters, 285, 61-65. (Pubitemid 30224624)
82. Mena, M. A., de Bernardo, S., Casarejos, M. J., et al. (2002). The role of astroglia on the survival of dopamine neurons. Molecular Neurobiology, 25, 245-263. (Pubitemid 34665093)
83. Mizuta, I., Ohta, M., Ohta, K., et al. (2001). Riluzole stimulates nerve growth factor brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neuroscience Letters, 310, 117-120. (Pubitemid 32822818)
84. Moe, K. T., Aulia, S., Jiang, F., et al. (2006). Differential upregula-tion of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. Journal of Cellular and Molecular Medicine, 10, 231-239. (Pubitemid 44874305)
85. Moncada, S., & Higgs, E. A. (2006). The discovery of nitric oxide and its role in vascular biology. British Journal of Pharmacology, 147, S193-S201. (Pubitemid 43077277)
86. Morgan, J. M., & Liu, Z. G. (2010). Reactive oxygen species in TNF-α induced signaling and cell death. Molecular Cell, 30, 1-12.
87. Nagatsu, T., Mogi, M., Ichinose, H., et al. (2000). Changes in cy-tokines and neurotrophins in Parkinson's disease. Journal of Neural Transmission 60(Suppl.), 277-290. (Pubitemid 32037200)
88. Nagatsu, T., & Sawada, M. (2005). Infammatory process in Parkinson's disease: Role for cytokines. Current Pharmaceutical Design, 11, 999-1016. (Pubitemid 40331301)
89. Nakazawa, T., Morii, H., Tamai, M., et al. (2005). Selective upreg-ulation of rb3/stathmin4 by ciliary neurotrophic factor following optic nerve axotomy. Brain Research, 1061, 97-106. (Pubitemid 41587917)
90. Nayak, D., Huo, Y., Kwang, W. X., et al. (2010). Sphingosine kinase 1 regulates the expression of proinfammatory cytokines and nitric oxide in activated microglia. Neuroscience, 166, 132-144.
91. Nedergaard, M., Rodŕiguez, J. J., & Verkhratsky, A. (2010). Glial calcium and diseases of the nervous system. Cell Calcium, 47, 140-149.
92. Newburger, P. E., Dai, Q., & Whitney, C. (1991). In vitro regulation of human phagocyte cytochrome b heavy and light chain gene expression by bacterial lipopolysaccharide and recombinant human cytokines. Journal of Biological Chemistry, 266, 16171-16177. (Pubitemid 21907780)
93. Ohta, K., Fujinami, A., Kuno, S., et al. (2004). Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture. Pharmacology, 71, 162-168. (Pubitemid 38716232)
94. Ohta, M., Mizuta, I., Ohta, K., et al. (2000). Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astro-cytes. Biochemical and Biophysical Research Communications, 272, 18-22. (Pubitemid 30444892)
95. Olivieri, G., Otten, U., Meier, F., et al. (2003). Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neu-roblastoma cells: Infuence of the antioxidant melatonin. Neu-roscience, 120, 659-665. (Pubitemid 36928064)
96. 2-induced neuronal death. Neurobiology of Disease, 20, 141-154. (Pubitemid 41219211)
97. Orellana, D. I., Quintanilla, R. A., & Maccioni, R. B. (2007). Neuro-protective effect of TNF-alpha against the beta-amyloid neuro-toxicity mediated by cdk5 kinase. Biochimica et Biophysica Acta, 1773, 254-263. (Pubitemid 46138002)
98. Park, K. W., Baik, H. H., & Jin, B. K. (2008). Interleukin-4-induced oxidative stress via microglial NADPH oxidase contributes to the death of hippocampal neurons in vivo. Current Aging Science, 1, 192-201.
99. Pataky, D. M., Borisoff, J. F., Fernandes, K. J., et al. (2000). Fibrob-last growth factor treatment produces differential effects on survival and neurite outgrowth from identifed bulbospinal neurons in vitro. Experimental Neurology, 163, 357-372. (Pubitemid 30399084)
100. Pehar, M., Cassina, P., Vargas, M. R., Castellanos, R., Viera, L., Beck-man J.S., Estevez A.G., Barbeito L. (2004). Astrocytic production of nerve growth factor in motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. Journal of Neurochemistry, 89, 464-473. (Pubitemid 38495994)
101. Peuchen, S., Bolanos, J. P., Heales, S. J., et al. (1997). Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Progress in Neurobiology, 52, 261-281. (Pubitemid 27306870)
102. Przedborski, S. (2010). Infammation and Parkinson's disease patho-genesis. Movement Disorders, 25, S55-S57.
103. Qin, B., Cartier, L., Dubois-Dauphin, M., et al. (2006). A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiology of Aging, 27, 1577-1587. (Pubitemid 44349157)
104. Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J. S., et al. (2007). Systemic LPS causes chronic neuroinfammation and progressive neurodegeneration. Glia, 55, 453-462. (Pubitemid 46383175)
105. Ridet, J. L., Malhotra, S. K., Privat, A., et al. (1997). Reactive astro-cytes: Cellular and molecular cues to biological function. Trends Neuroscience, 20, 570-577. (Pubitemid 27508969)
106. Rojo, L. E., Fernandez, J. A., Maccioni, A. A., et al. (2008). Neuroin-fammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Archives of Medical Research, 39, 1-16. (Pubitemid 350192021)
107. Rossi, F., & Bianchini, E. (1996). Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochemical and Biophysical Research Communications, 225, 474-478. (Pubitemid 26355625)
108. Saavedra, A., Baltazar, G., Santos, P., et al. (2006). Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron-glia crosstalk. Neurobiol-ogy of Disease, 23, 533-542. (Pubitemid 44234089)
109. Sandhu, J. K., Gardaneh, M., Iwasiow, R., et al. (2009). Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiology of Disease, 33, 405-414.
110. Savaskan, N. E., Borchert, A., Brauer, A. U., et al. (2007). Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: Specifc induction of enzyme expression in reactive as-trocytes following brain injury. Free Radical Biology and Medicine, 43, 191-201. (Pubitemid 46977163)
111. Seifert, G., Schilling, K., & Steinhauser, C. (2006). Astrocyte dysfunction in neurological disorders: A molecular perspective. Nature Reviews Neuroscience, 7, 194-206. (Pubitemid 43292465)
112. Semkova, I., Wolz, P., Schilling, M., et al. (1996). Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. European Journal of Pharmacology, 315, 19-30. (Pubitemid 26390945)
113. Sharma, J. N., Al-Omran, A., & Parvathy, S. S. (2007). Role of nitric oxide in infammatory diseases. Inflammopharmacology, 15, 252-259. (Pubitemid 351196133)
114. Shimohama, S., Tanino, H., Kawakami, N., et al. (2000). Activation of NADPH oxidase in Alzheimer's disease brains. Biochemical and Biophysical Research Communications, 273, 5-9. (Pubitemid 30426853)
115. Singh, S., Das, T., Ravindran, A., Chaturvedi, R. K., et al. (2005). Involvement of nitric oxide in neurodegeneration: A study on the experimental models of Parkinson's disease. Redox Report, 10, 103-109. (Pubitemid 44110218)
116. Singh, S., & Dikshit, M. (2007). Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide. Brain Research Reviews, 54, 233-250. (Pubitemid 46891075)
117. Singh, S., Kumar, S., & Dikshit, M. (2010). Involvement of mi-tochondrial apoptotic pathway and nitric oxide synthase in 6-hydroxydopamine and lipopolysacchride induced dopaminergic neuronal death. Redox Report, 15, 1-8.
118. Skaper, S. D., Ancona, B., Facci, L., et al. (1998). Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB Journal, 12, 725-731. (Pubitemid 28247151)
119. Sofroniew, M. V., & Vinters, H. V. (2010). Astrocytes: Biology and pathology. Acta Neuropathology, 119, 7-35.
120. Spina, M. B., Squinto, S. P., Miller, J., et al. (1992). Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion tox-icity: Involvement of the glutathione system. Journal of Neuro-chemistry, 59, 99-106.
121. Swarnkar, S., Tyagi, E., Agrawal, R., et al. (2009). A comparative study on oxidative stress induced by LPS and rotenone in ho-mogenates of rat brain regions. Environmental Toxicology and Pharmacology, 27, 219-224.
122. Szelényi, J. (2001). Cytokines and the central nervous system. Brain Research Bulletin, 54, 329-338. (Pubitemid 32288713)
123. Takuma, K., Baba, A., & Matsuda, T. (2004). Astrocyte apoptosis: Implications for neuroprotection. Progress in Neurobiology, 72, 111-127. (Pubitemid 38519589)
124. Takuma, K., Yoshida, T., Lee, E., et al. (2000). CV-2619 protects cultured astrocytes against reperfusion injury via nerve growth factor production. European Journal of Pharmacology, 406, 333-339.
125. Tang, L. L., Wang, R., & Tang, X. C. (2005). Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production. European Journal of Pharmacology, 519, 9-15. (Pubitemid 43181158)
126. Temporin K., Tanaka H., Kuroda Y., et al. (2008). Interleukin-1 beta promotes sensory nerve regeneration after sciatic nerve injury. Neuroscience Letters, 440, 130-133.
127. Valles, S. L., Dolz-Gaiton, P., Gambini, J., et al. (2010). Estradiol or genistein prevent Alzheimer's disease-associated infammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Research, 1312, 138-144.
128. Venters, H. D., Dantzer, R., & Kelley, K. W. (2000). A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neuroscience, 23, 175-180. (Pubitemid 30151214)
129. Vogt, C., Hailer, N. P., Ghadban, C., et al. (2008). Successful inhibition of excitotoxic neuronal damage and microglial activation after delayed application of interleukin-1 receptor antagonist. The Journal of Neuroscience Research, 86, 3314-3321.
130. Wiggins, A. K., Shen, P. J., Gundlach, A. L. (2003). Delayed but prolonged increases in astrocytic clusterin (ApoJ) mRNA expression following acute cortical spreading depression in the rat: Evidence for a role of clusterin in ischemic tolerance. Brain Research Molecular Brain Research, 114, 20-30. (Pubitemid 36627992)
131. Wilde, G. J., Pringle, A. K., Sundstrom, L. E., et al. (2000). Attenuation and augmentation of ischaemia-related neuronal death by tumour necrosis factor-alpha in vitro. The European Journal of Neuroscience, 12, 3863-3870.
132. Wilson, J. X. (1997). Antioxidant defense of the brain: A role for as-trocytes. Canadian Journal of Physiology and Pharmacology, 75, 1149-1163. (Pubitemid 28033933)
133. Wyss-Coray, T. (2006). TGF-beta pathway as a potential target in neurodegeneration and Alzheimer's. Current Alzheimer Research, 3, 191-195. (Pubitemid 43988131)
134. Yamamoto, M., Kiyota, T., Horiba, M., et al. (2007). Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. American Journal of Pathology, 170, 680-692. (Pubitemid 47339404)
135. 2-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha. International Immunopharmacology, 8, 1377-1385.
136. Zhao, W., Xie, W., Xiao, Q., et al. (2006). Protective effects of an anti-infammatory cytokine, interleukin-4, on motoneuron tox-icity induced by activated microglia. Journal of Neurochemistry, 99, 1176-1187. (Pubitemid 44655283)
137. Zheng, L. T., Ock, J., Kwon, B. M., & Suk, K. (2008). Suppres-sive effects of favonoid fsetin on lipopolysaccharide-induced mi-croglial activation and neurotoxicity. International Immunophar-macology, 8, 484-494.